EP1853265

FARNESYLTRANSFERASE INHIBITORS FOR USE IN THE TREATMENT OF LAMINOPATHIES, CELLULAR AGING AND ATHEROSCLEROSIS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    27.1.2006
  • EP published:
    27.1.2016
  • EP application number:
    06733984.6
  • Max expiry date:
    26.1.2026
  • Title:
    FARNESYLTRANSFERASE INHIBITORS FOR USE IN THE TREATMENT OF LAMINOPATHIES, CELLULAR AGING AND ATHEROSCLEROSIS

Timeline

Today
27.1.2006EP application
27.1.2016EP Publication

Owner

  • Name:
    The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services
  • Address:
    National Institutes of Health, Suite 325, 6011 Executive Boulevard, 20852-3804, Rockville, MD, US
  • Name:
    The Progeria Research Foundation, Inc.
  • Address:
    P.O. Box 3453, 01961-3453, Peabody, MA, US
  • Name:
    THE REGENTS OF THE UNIVERSITY OF MICHIGAN
  • Address:
    Wolverine Tower Room 2071, 3003 South State Street, 48109-1290, Ann Arbor,Michigan, US
  • Name:
    THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
  • Address:
    Office of Technology Development, Campus Box 4105, 308 Bynum Hall, 27599-4105, Chapel Hill, NC, US

Inventor

  • Name:
    GORDON, Leslie, B.
  • Address:
    Foxboro, MA, US
  • Name:
    COLLINS, Francis, S.
  • Address:
    Rockville, MD, US
  • Name:
    GLOVER, Thomas
  • Address:
    Ypsilanti, MI, US
  • Name:
    GLYNN, Michael, W.
  • Address:
    Darien, CT, US
  • Name:
    CAPELL, Brian, C.
  • Address:
    Rumson, NJ, US
  • Name:
    COX, Adrienne, D.,c/o Dept. Radiation Oncology
  • Address:
    Chapel Hill, NC, US
  • Name:
    DER, Channing, J.,c/o Lineberger Comp.Cancer Ctr.
  • Address:
    Chapel Hill, NC, US

Priority

  • Number:
    648307 P
  • Date:
    28.1.2005
  • Country:
    US
  • Number:
    707192 P
  • Date:
    9.8.2005
  • Country:
    US

Classification

  • Categories:
    A61K 31/4704, A61K 31/221, A61K 31/255, A61K 31/445, A61K 31/473, A61P 43/00

Upload documents